Thyroid Pathology Flashcards

1
Q

is thyroid bigger in men or women

A

slightly larger in women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what level is the thyroid

A

C5/6-T1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

describe the embryological development of the thyroid gland

A

develops from evagination of pharyngeal epithelium

descends from foramen caecum to normal location along the thryoglossal duct

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the three common embryological abnormalities of the thryoid

A

failure of descent (lingual thyroid)
excessive descent (retrosternal location in mediastinum)
thyroglossal duct cyst

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what makes up the thyroid

A

composed of follicles that are surrounded by flat cuboidal follicular epithelial cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is in the centre of each follicle

A

dense amorphic pink material containing thryoglobulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what cells are scattered throughout the thyroid gland

A

C cells (parafollicular)- have slightly larger with clearer cytoplasms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what do C cells produce

A

calcitonin- lowers serum Ca

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what cells produce thyroid hormones

A

thyroid follicular epithelium cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

describe how TSH works

A

binds to TSH surface receptor on surface of thyroid epithelial cells. G proteins activated with conversion of GTP to GDP and production of cAMP which stimulates production and release of T3 and 4, circulate in bound and free forms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what happens when T3 binds to receptors in target cells

A

complex translocates to the nucleus, binds to thyroid response elements on target genes, stimulates transcription of these genes- increase BMR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what can cause a thyroid gland to shrink in size

A

atrophy- presentation of reduced function a

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what can a mass effect if an enlarged thyroid gland be

A

airway obstruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

polymorphisms in what genes are associated with autoimmune thyroid problems

A

CTLA-4 (negative regulator of T cell responses)

PTPN-22 (inhibits T cell function)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are causes of inflammation in the thyroid

A

autoimmune disordersm infection, palpation, subacute lymphocytic, de Quervains, riedels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what does riedels do to the thyroid

A

makes it hard, claggy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what autoimmune disease causes hypothyroidism

A

hashimotos thyroiditis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what autoimmune disease causes 8% of hyperthyroidism cases

A

graves disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what is thyrotoxoicosis

A

hyperthyroidism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what else can cause hyperthyroidism

A

hyperfunctioning nodules, tumours (adenomas, carcinomas)
TSH secreting pituitary adenomas (rare),
thyroditis, ectopic production (struma ovarii)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

is graves more common in men or women

A

women 10:1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what age to people gets graves

A

20-40 years old

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

what is the triad of symptoms seen in graves

A

hyperthyroidism with diffuse enlargement of the thryoid
eye changes (exophthalamos),
partial myxoedema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

what autoantibodies are seen in graves

A

Antibodies to TSH receptor, thyroid peroxisomes and thyroglobulin.

Anti TSH receptor antibodies: thyroid stimulating immunoglobulin, thyroid growth stimulating immunilogbulin,
TSH binding inhibitor immunoglobulins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

what do the antibodies in graves do

A

stimulate thyroid hormone to function- except TSH binding inhibitor which causes episodes of hypofunction seen in graves

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

what is seen histologically in graves

A

thyroid follicles lack the ‘pink collar’ of follicular cells aka scalloping due to uptake of colloid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

what causes symptoms in hypothyroidism

A

lack of thyroid hormones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

who gets hashimotos

A

middle aged women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

what genes is hashimotos associated

A

HLA- DR3 and DR5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

what else can cause hypothyroidism

A

iodine deficiency, drugs (lithium), post therapy (surgery, irradiation), congenital abnormalities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

what is hashimotos thyroiditis

A

autoimmune disease which causes gradual failure of thyroid function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

what antibodies are in hashimotos thyroiditis

A

anti thyroid antibodies
(anti thyroglobulin and anti peroxidase)
when bound cause anti body dependent cell mediated cytotoxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

what cells mediate hashimotos thyroiditis

A

CD8 +ve cells (destroy cell epithelium)
cytokine mediated cell death (gamma interferon from T cell activation recruits macrophages that may damage thyroid follicles)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

what is the histology of hashimotos

A

follicles that remain dont have scalloping as retention of thyroid hormone
inflammatory infiltrate

35
Q

what might hashimotos thyroiditis be preceded by

A

transient hyperfunction (hashitoxicosis)

36
Q

what cancer is at increased risk in hashimotos thyroiditis

A

B cell non hogkins lymphoma

37
Q

what is a goitre

A

any enlargement of the thyroid gland

38
Q

what commonly causes goitres

A

lack of dietary, reduced T3/4 production causing rise in TSH which stimulates gland enlargement

39
Q

who gets diffuse goitres

A

females more than men, puberty and young adults

40
Q

what causes a diffuse goire

A

ingestion of substances limiting T3/4 production, dyshormogenesis, idiopathic (most)

41
Q

what are the usual symptoms of a goitre

A

usually euthyroid

presents with mass effects- cosmesis, airway obstruction, dysphagia, compresses vessels

42
Q

what can dyshormogenesis cause in children

A

cretinism

43
Q

what is seen in blood test in diffuse goitres

A

normal thyroid hormones but increase or upper side of normal TSH

44
Q

what causes a multinodular goitre

A

recurrent hyperplasia and involution, mutations in TSH, rupture of follicles, haemorrhage, scarring, calcification

45
Q

what do many multi nodular goitres develop

A

autonomous nodule- hyperthyroid

46
Q

describe the structure of a thyroid adenoma

A

discrete solitary mass, encapsulated by a surrounding collagen cuff, composed of neoplastic thyroid follicles (follicular adenoma)

47
Q

are thyroid adenomas benign

A

yes

48
Q

what is it hard to differentiate a thyroid adenoma from

A

dominant nodule in multinodular goitre, follicular carcinoma

49
Q

what are the effects of an adenoma

A

mass effects

usually non functional- can secrete thyroid hormones (thyrotoxicosis)- are TSH independent

50
Q

what mutations are seen in thyroid adenomas

A

<20% have mutant ras or PIK3CA

mutations of TSHR signalling pathway in functional adenomas
-activating TSHR, G proteins which increases cAMP levels

51
Q

what cells do thryoid malignancies come from

A

follicular epithelium (medullary from C cells)

52
Q

list the thyroid malignancies from most to least common

A

papillary (75-85%), follicular, medullary, anaplastic

53
Q

what is the aetiology of each of the thryoid cancers

A

environment-radiation (papillary), iodine deficiency (follicular)

genetics-
papillary- activate MAP kinase pathway, activation of BRAF, mutation in ras
follicular- mutations in ras family
anaplastic- above + p53 and beta-catenin mutations
medullary- MEN2

54
Q

what is the most common thyroid malignancy

A

papillary

55
Q

what is the usual structure of papillary carcinomas

A

usually solitary, can be mutlifocal, often cystic, may be calcified (psammoma bodies)

56
Q

do papillary carcinomas spread via the lymph

A

yes

if find thyroid tissue or psammoma body in a lymph node look for occult papillary carcinoma

57
Q

how do papillary carcinomas present

A

lesion in thyroid gland or cervical lymph node mass (metastasis)

local effects:
-hoarseness
-dysphagia
-cough 
-dyspnoea 
(all suggest locally advanced disease)
58
Q

do papillary carcinomas spread via the lung

A

not usually- if they do its commonly to the lung

59
Q

what is the second most common thyroid carcinoma

A

follicular

60
Q

who gets follicular carcinomas

A

F>M, older than papillary (40s and 50s)

61
Q

when is there not a female predominance in thyroid carcinomad

A

childhood and old age

62
Q

what are the survival rates for papillary carcinoma

A

95% at 10 years

63
Q

follicular carcinomas: onset, character and spread

A

slowly enlarging, painless, non functional, invasive growth pattern

dont spread via the lymph (unlike papillary) but spread haematogenous spread to the bones lungs and liver

64
Q

describe the structure of widely invasive follicular carcinomas

A

more solid architecture, less follicular architecture, more mitotic activity

65
Q

describe the structure of minimally invasive follicular carcinomas

A

follicular architecture (well differentiated), may have surrounding capsule, hard to distinguish from adenoma

66
Q

what is the difference between follicular adenoma and carcinoma

A

carcinoma need vascular or capsular invasion

67
Q

what is the prognosis for follicular carcinoma

A

depends on extent of invasion and stage of presentation

if high stage at presentation 50% mortality at 10 years

less invasive 90% at 10 years

68
Q

what is autoimmune thyroiditis

A

hashimotos

69
Q

what type of tumour is a medullary thyroid carcinoma

A

neuoendocrine (derived from C cells)

70
Q

what can medullary thyroid carcinoma secrete

A

calcitonin

71
Q

what are the forms of medullary thyroid carcinoma

A

can be specific, associated with multiple endocrine neoplasm, familial

72
Q

what type of medullary thyroid carcinoma can arise in very young patients

A

MEN cases

73
Q

who gets sporadic and familial medullary thyroid carcinoma

A

40s-50s

74
Q

what form do sporadic medullary carcinomas take

A

solitary nodules

75
Q

what form do familial medullary carcinomas take

A

bilateral/ multicentric (c cell hyperplasia)

76
Q

what is the histology of medullary carcinomas

A

spindle or polygonal cells arranged in nests, trabeculae or follicles
associated amyloid deposition

77
Q

what paraneoplastic syndromes are seen in medullary carcinomas

A

diarrhoea (VIP production)

cushings (ACTH production)

78
Q

what is the treatment for medullary carcinoma

A

total thyroidectomy

79
Q

what is the survival rates for medullary carcinoma

A

70-80% in 5 years

80
Q

what are the good prognostic factors for medullary carcinoma

A

young, female, familial setting, tumour size, confined to the gland

81
Q

what histological features suggest a tumour with more aggressive behavior

A

necrosis, many mitosis, small cell morphology

82
Q

describe anaplastic carcinomas

A

undifferentiated and aggressive tumours

rapid growth an involvement of neck structure and death

83
Q

who gets anaplastic carcinomas

A

older patients

people with a history of differentiated thyroid cancer